NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001869

Registered date:10/04/2009

A randomized, double blind, comparative study of STATUS D3 (vitamin D3) versus placebo in patients with lung cancer to prevent relapse after operation

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedlung cancer
Date of first enrollment2009/05/01
Target sample size300
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)vitamin D3 suppliment placebo

Outcome(s)

Primary Outcomedisease free survival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1. Already taking vitamin D supplement or 1,25 vitamin D 2. History of kidney stone 3. Other difficulties judged by the surgeon in charge

Related Information

Contact

public contact
Name Emi Suzuki
Address Japan
Telephone
E-mail emisuzu@jikei.ac.jp
Affiliation Jikei University School of Medicine Division of Molecular Epidemiology
scientific contact
Name Mitsuyoshi Urashima
Address 3-25-8 Nishi-shimbashi Minato-ku, Tokyo Japan
Telephone 03-3433-1111
E-mail
Affiliation Jikei University School of Medicine Division of Molecular Epidemiology